NCT02495493View on ClinicalTrials.gov

S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2019

Study Completion Date

July 31, 2019

Conditions
Gastric Adenocarcinoma
Interventions
DRUG

Induction DCS chemotherapy

docetaxel /cisplatin/S-1 followed by chemoradiotherapy (S-1/cisplatin)

Trial Locations (1)

120-752

Severance Hospital, Yonsei University Health System, Yonsei Cancer Center, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02495493 - S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter